UAEのヘルスケア市場見通し

◆英語タイトル:UAE Healthcare Market Outlook to 2020 - Rising Medical Tourism and High Prevalence of Diabetes to Foster Future Growth
◆商品コード:KENR60821
◆発行会社(調査会社):Ken Research
◆発行日:2016年6月
◆ページ数:278
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:UAE
◆産業分野:医療
◆販売価格オプション(消費税別)
Electronic Individual(1名利用)USD1,800 ⇒換算¥205,200見積依頼/購入/質問フォーム
Enterprisewide(全社内利用可)USD3,400 ⇒換算¥387,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKen Research社の日本における正規販売代理店です。Ken Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

The publication titled, “UAE Healthcare Market Outlook to 2020 – Rising Medical Tourism and High Prevalence of Diabetes to Foster Future Growth” focuses on the medical devices used in the hospital setting, diagnostic laboratories, clinics and polyclinics, pharmaceutical drugs and injectables used for treatment and diagnostic purposes, and services provided by healthcare providers for maintaining healthy population. The report covers aspects such as overall healthcare market by its key segments including medical devices, pharmaceuticals, hospitals, independent diagnostic laboratories, clinics/polyclinics, home healthcare and telemedicine and their sub-segments.
UAE healthcare market is one of the fastest growing markets in the world with the growth rate of ~% from 2010 to 2015. The market is also expected to experience high growth during the forecast period and exhibit a CAGR of ~% from 2016 to 2020.

Medical Device Market
UAE is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2015. The market is observed to grow at a rapid pace of ~% by value from 2010 to 2015 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector is investing heavily to provide country satisfactory healthcare solutions to the residents, expats, and medical tourists. Diagnostic imaging products were observed to capture the major share of the market (~% in 2015), however medical consumables recorded the highest growth rate of 17.2% in span of six years from 2010 to 2015. UAE being the economically stable country, the healthcare professionals across the nation prefer the branded medical devices from GE Healthcare, Philips Medical Systems, and Siemens Healthineers, providing all of them leading position in the market. The three players together captured around ~% of the total revenue share in 2015. The market is further expected to register a growth of ~% from 2016 to 2020, and reach at a value of USD ~ million in 2020. Orthopedic devices are expected to register the highest growth during the period specifically due to aging population.

Pharmaceutical Market
Pharmaceuticals market is the UAE similar to medical devices is dependent upon imports of pharmaceutical products. Imports accounted for ~% of the total revenue in 2015 for pharmaceuticals market in the UAE. The total pharmaceuticals market in UAE has exhibited the growth rate of ~% from 2010 to 2015. Patented drugs are observed to be preferred more than generic drugs and have captured the revenue share of ~% in 2015, however generic drugs have experienced high growth rate of ~% from 2010 to 2015 and is estimated to expand at a CAGR of ~% during the forecast period. Julphar is the major domestic player who is manufacturing drugs for the UAE pharmaceuticals market. The company accounted for total of ~% of the domestic manufacturers share in 2015. Among the prescribed and OTC drugs, prescribed drugs accounted for ~% of the share. Patented drugs are majorly imported from the other countries to meet the high demand among the nationals. City Pharmacy was observed to import highest value of drugs in 2015 and accounted for ~% of the total importers share.

Pharmacy Retail Market
Pharmacy retail is a fast growing market with the growth rate of ~% from 2010 and 2015, and the market revenue of USD ~ million and USD ~ million in the respective years. Elevating demand for pharmaceutical goods, and home use devices the major factor which has led to the growth of the segment. Majority of the pharmacies (~%) are observed to be based in Dubai, generating revenue from tourists and medical tourists. Various organized players such as Life Pharmacy, Bin Sina Pharmacy, Aster Pharmacy, and Super Pharmacy are dominated the market by capturing major share of the market.

Hospitals Market
Hospitals market in UAE has experienced rapid increase in number of hospitals, number of inpatients and outpatients from 2010 to 2015. Number of hospitals recorded the growth rate of ~%, however, number of inpatients and outpatients increased by ~% and ~% respectively. Rise in number of patients has resulted in revenue generation at a high pace, exhibiting a growth rate of ~%. Private hospital was observed to be major revenue generator with ~% of revenue share in 2015, while public hospitals recorded the growth rate of ~%. The major revenue contributor among private and public hospitals was multispecialty hospitals with market share of ~%. However, the establishment of single-specialty hospitals was on high speed from 2010 to 2015, increasing the revenue at a rate of ~% in the respective years. Multi-specialty hospital group NMC healthcare dominated the market with the revenue share of ~% during this period.

Independent Diagnostic Laboratories Market
Independent diagnostic laboratories is most recently established market in the UAE with revenue of USD ~ million and growth rate of ~% in span of six years (2010 – 2015). The rising self care attitude among people coupled with increasing prevalence of chronic diseases is the major factor which has led to growth of independent diagnostic laboratories. These laboratories are actively engaged in providing pathology tests, and pathology tests contribute approximately ~% of the total revenue in 2015. Radiology tests generated low share of the market majorly due to presence of limited number of radiology services including X-ray and ultrasound. Organized players including Proficiency Healthcare Diagnostics, National Radiology Laboratory, Al Borg Laboratories and Medsol Laboratories captured major share of the market with revenue share of approximately ~%. Proficiency Healthcare Diagnostics led the market with ~% share.

UAE Telemedicine Market
Emergence of Abu Dhabi Telemedicine Center in 2013 marked the initiation of core telemedicine services in the UAE. The center has experienced a high growth during this period with revenue of USD ~ million in 2013 and USD ~ million in 2015, and the market is expected to grow at a CAGR of ~% during the forecast period. Prior to this, teleradiology was the only segment which was generating revenue for UAE in telemedicine market. Teleradiology segment has experienced the growth rate of ~% from 2010 to 2015.

UAE Home Healthcare Market
Home healthcare market is newly established market with large number of unorganized players operating in the market. Americare Home Health Services, Manzil Healthcare Services, and Emirati Canadian Home Healthcare Services are the major among many. The market has exhibited the growth by ~% in between 2010 to 2015 and is expected to experience growth rate of ~% during the forecast period. Aging population and high prevalence of diabetes leading to kidney failures and subsequently increase in demand for home peritoneal dialysis are the major factors which are expected to contribute in the growth of the market.

Key Topics Covered in the Report:
◾The market size of UAE Healthcare Market
◾Market segmentation of UAE Healthcare market on the basis – By Healthcare Segments – Medical Devices, Pharmaceuticals, Hospitals, Independent Diagnostic Laboratories, Clinics/Polyclinics, Home Healthcare and Telemedicine
◾The market size of UAE Medical Devices Market
◾Market segmentation of UAE medical devices market on the basis
◾The market size of UAE pharmaceuticals Market
◾Market segmentation of UAE pharmaceuticals market on the basis
◾The market size of UAE hospitals Market
◾Market segmentation of UAE hospitals market on the basis
◾The market size of UAE independent diagnostic laboratories Market
◾Market segmentation of UAE independent diagnostic laboratories market on the basis
◾The market size of UAE clinics/polyclinics Market
◾Market segmentation of UAE clinics/polyclinics market on the basis
◾The market size of UAE Telemedicine Market
◾The market size of UAE Home Healthcare Market
◾The market size of UAE Pharmacy Retail Market
◾SWOT Analysis of UAE Healthcare Market
◾Trends and Developments in UAE Healthcare Market
◾Investment Model of UAR Hospitals Market
◾Revenue Stream of Independent Diagnostic Laboratories
◾Purchase Decisions regarding Medical Devices
◾Competitive landscape and detailed company profiles of the major market players
◾Government Regulations in UAE Healthcare Market
◾Future outlook and projections of UAE Healthcare Market
◾Analyst Recommendations
◾Macro-economic Factors Impacting the UAE Healthcare Market

【レポートの目次】

1. Executive Summary
Market Potential
Market Segmentation
Medical Devices Market
Pharmaceuticals Market
Pharmacy Retail Market
Hospitals Market
Independent Diagnostic Laboratories Market
UAE Clinics/Polyclinics Market
UAE Telemedicine Market
UAE Home Healthcare Market
Macroeconomic Factors
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Approach – Market Sizing
Market Sizing – Overall Healthcare Market
Market Sizing – Medical Devices and Pharmaceuticals Market
Market Sizing – Hospitals Market
Market Sizing – Independent Diagnostic Laboratories Market
Market Sizing – Telemedicine Market
Market Sizing – Home Healthcare Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Limitations
Final Conclusion
3. UAE Healthcare Market, CY2010 – CY2015
3.1. UAE Healthcare Statistics
3.2. UAE Healthcare Regulatory Bodies
3.3. Health Insurance in UAE
3.4. UAE Imports Scenario
3.4.1. UAE Imports Procedure
3.4.2. Essential Documents for Imports of Goods into UAE
3.5. UAE Healthcare Market Size, CY2010 – CY2015
4. UAE Medical devices Market Size By Value, CY2010 -CY2015
4.1. UAE Medical Devices Market Segmentation, CY2010 – CY2015
4.1.1. By Type of Application,
4.1.2. By Institutional and Household Demand, CY2010 – CY2015
4.1.3. By Domestic Demand and Imports, CY2010 – CY2015
4.1.4. By Emirates, CY2015
4.2. Imports of Medical Devices in UAE
4.2.1. Import Duties
4.2.2. Segmentation of Imported Medical Devices in UAE, CY2012 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2012 – CY2014
4.3. Exports of Medical Devices by UAE
4.3.1. Segmentation of Exported Medical Devices in UAE, CY2012 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2012 – CY2014
4.4. Regulatory Environment for Medical Devices in UAE
4.5. Trends and Developments in UAE Medical Devices Market
4.5.1. Rising Investments on Healthcare Infrastructure
4.5.2. Partnerships with Medical Devices Giants
4.5.3. Growing Demand for Wearable Smart Medical Devices
4.5.4. Demand for Innovative Products in the UAE
4.6. UAE Medical Devices Market Competitive Landscape
4.6.1. Company Profiles for Importers in UAE Medical Devices Market
Gulf Drug LLC
Abu Dhabi International Medical Services (ADI)
Modern Pharmaceutical Company Healthcare (MPC)
Pharmatrade LLC
Atlas Medical
4.7. Market Share of Major Market Players in UAE Medical Devices Market, CY2015
4.7.1. Importers
4.7.2. Manufacturers
4.8. Decision Making Process to Shortlist Medical Device
4.9. Future Outlook and Projections, CY2016 – CY2020
5. UAE Pharmaceuticals Market Size by Value, CY2010 – CY2015
5.1. UAE Pharmaceuticals Market Segmentation
5.1.1. By Generic and Patented Drugs, CY2010 – CY2015
5.1.2. By OTC and Prescribed Drugs, CY2010 – CY2015
5.1.3. By Domestic Demand and Imports, CY2010 – CY2015
5.1.4. By Therapeutic Area, CY2010 – CY2015
5.1.5. By Emirates, CY2015
5.2. Imports of Pharmaceuticals in UAE
5.2.1. Import Duties
5.2.2. Segmentation of Imported Pharmaceuticals, CY2010 – CY2014
By Type of Products, CY2012 – CY2014
By Major Countries, CY2010 – CY2014
5.3. Exports of Pharmaceuticals by UAE
5.3.1. Segmentation of Exported Medical Devices in UAE, CY2010 – CY2014
By Type of Products, CY 2010 – CY2014
By Major Countries, CY2012 – CY2014
5.4. Regulatory Environment for Pharmaceuticals in UAE
5.5. UAE Patent Approval Procedure
5.6. Trends and Developments in UAE Pharmaceuticals Market
5.6.1. Establishment of Free Zone, DuBiotech
5.6.2. Rising Generic Drug Production
5.6.3. Slashing Drugs Prices in the UAE
5.7. UAE Pharmaceuticals Market Competitive Landscape
5.7.1. Company Profiles for Domestic Manufacturers in UAE Pharmaceuticals Market
Julphar
Neopharma
Globalpharma
Medpharma
5.8. Market Share of Major Market Players in UAE Pharmaceuticals Market, CY2015
5.8.1. Domestic Manufacturers
5.8.2. Importers
5.8.3. International Manufacturers
5.9. Key Pharmaceutical Products Launched in UAE, CY2010 – CY2015
5.10. Future Outlook and Projections, CY2016 – CY2020
6. Snapshot on UAE Pharmacy Retail Market
6.1. Company Profiles for Major Retail Pharmacies
6.1.1. Life Pharmacy
6.1.2. Bin sina
6.1.3. Aster Pharmacy
6.1.4. Super Care Pharmacy
6.2. Margins of Retail Pharmacies
7. UAE Hospitals Market Size
7.1. By Revenue, CY2010 – CY2015
7.2. By Number of Hospitals, CY2010 – CY2015
7.3. By Number of Beds, CY2010 – CY2015
7.4. By Inpatients, CY2010 – CY2015
7.5. By Outpatients, CY2010 – CY2015
7.6. UAE Hospitals Market Segmentation
7.6.1. By Public and Private Hospitals, CY2010 – CY2015
7.6.2. By Different Services, CY2010 – CY2015
7.6.3. By Single and Multi-Specialty, CY2010 – CY2015
7.6.4. By Emirates, CY2015
7.7. Regulatory Environment for Hospitals in UAE
7.8. UAE Hospitals JCI Accreditation
7.9. Trends and Developments in UAE Hospitals Market
7.9.1. Partnerships
7.9.2. Acquisitions
7.9.3. Medical Overseas Visits by Emiratis
7.10. UAE Hospitals Business Model
7.11. Investment Model in UAE Hospitals Market
7.11.1. Initial Investment
7.11.2. Annual Cost
7.11.3. Average Annual Revenue Generated by a Hospital in UAE
7.11.4. Inpatient Revenue
7.12. Major Hospital Projects Under Pipeline in UAE
7.13. UAE Hospitals Market Competitive Landscape
7.13.1. Company Profiles
NMC Healthcare
Zulekha Hospital
American Hospital
Mediclinic Middle East
Al Zahra Hospital
Cleveland Clinic Abu Dhabi
VPS Healthcare
Aster DM Healthcare
7.14. Market Share of Major Market Players in UAE Hospitals Market, CY2015
7.15. Future Outlook and Projections, CY2016 – CY2020
8. Independent Diagnostic Laboratories Market, CY2010 – CY2015
8.1. By Revenue, CY2010 – CY2015
8.2. By Number of Independent Diagnostic Laboratories, CY2010 – CY2015
8.3. UAE Independent Diagnostic Laboratories Market Segmentation
8.3.1. By Radiology and Pathology Tests, CY2010 – CY2015
8.3.2. By Organized and Unorganized Players, CY2010 – CY2015
8.3.3. By Emirates, CY2010 – CY2015
8.4. Regulatory Environment for Diagnostic Laboratories Market
8.5. Trends and Developments in UAE Independent Diagnostic Laboratories Market
8.5.1. Consolidation of Laboratories
8.5.2. Entrance of Diagnostic Supplies Manufacturing Companies
8.5.3. Rising Demand for Pre-pregnancy Test
8.6. UAE Independent Laboratories Market Competitive Landscape
8.6.1. Company Profiles
AL Borg Laboratories
Proficiency Healthcare Diagnostics (PHD)
National Reference Laboratory (NRL)
Medsol Diagnostics
8.6.2. Market Share of Major Market Players in UAE Independent Diagnostic Laboratories Market, CY2015
8.6.3. Revenue Stream of UAE Independent Diagnostic Laboratories
8.7. Future Outlook and Projections, CY2016 – CY2020
9. Snapshot on UAE Clinics/Polyclinics Market
9.1. UAE Clinics/Polyclinics Market Segmentation, CY2010 – CY2015
9.1.1. By Clinics and Polyclinics, CY2010 – CY2015
9.1.2. By Public Clinics/Polyclinics and Private Clinics/Polyclinics, CY2010 – CY2015
9.1.3. By Outpatient and Diagnostic Services, CY2010 – CY2015
9.1.4. By Emirates, CY2010 – CY2015
9.2. Competitive Landscape in UAE Clinics/Polyclinics Market
9.3. Future Outlook and Projections, CY2016 – CY2020
10. Snapshot on UAE Telemedicine Market
10.1. Abu Dhabi Telemedicine Centre
10.2. Teleradiology
10.2.1. Competitive Landscape of Major Teleradiology Service Provider
Ver2
Global Hawk Imaging And Diagnostics (Ghid)
10.3. Challenge
Limited Number of Telemedicine Centers
10.4. Future Plans
Telemedicine Pilot
10.5. Regulatory Environment for Telemedicine in UAE
10.6. Future Outlook and Projections, CY2016 – CY2020
11. Snapshot on UAE Home Healthcare Market
11.1.1. Americare Home Health Services
11.1.2. Manzil Healthcare Services
11.1.3. Emirati Canadian Home Healthcare Services
12. SWOT Analysis for UAE Healthcare Market
13. Future of UAE Healthcare Market
13.1. Cause and Effect relationship Between Dependent And Independent Factors Prevailing In UAE Healthcare Market
13.2. Future Outlook and Projections, CY2016 – CY2020
13.3. Analyst Recommendations
13.4. Regulations Affecting Future of the UAE Healthcare Market
14. Macroeconomic Indicators
14.1. Per Capita Healthcare Spending in UAE
14.2. Rising Government Expenditure on Healthcare
14.3. Aging Population
14.4. High Prevalence of Diabetes and Obesity
14.5. Medical Tourism
Disclaimer
Contact Us

Figure 3-1: UAE Proportional Mortality Statistics on the basis of Major Causes of Death in terms of Percentage of Total Deaths, CY2013
Figure 3-2: UAE Healthcare Regulating Bodies Operating Model
Figure 3-3: UAE Sea Imports Process for Medical Devices, Pharmaceutical Drugs and Other Healthcare Supplies
Figure 3-4: UAE Air Imports Process for Medical Devices, Pharmaceutical Drugs and Other Healthcare Supplies
Figure 3-5: UAE Road Import Process for Medical Devices, Pharmaceutical Drugs and Other Healthcare Supplies
Figure 3-6: UAE Healthcare Market Size by Revenue in USD Million, CY2010 - CY2015
Figure 3-7: UAE Healthcare Market Segmentation (Medical Devices, Pharmaceuticals, Hospitals, Independent Diagnostic Centers, Clinics/Polyclinics, Home Healthcare, and Telemedicine) on the basis of Revenue Contribution in terms of USD Million, CY2015
Figure 4-1: UAE Medical Devices Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 4-2: UAE Medical Devices Market Segmentation by Type of Application (Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants, and Others) on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 4-3: UAE Medical Devices Market Segmentation by Institutional and Household Demand on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 4-4: UAE Medical Devices Market Segmentation by Institutional and Household Demand on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 4-5: Gulf Drugs LLC Operating History
Figure 4-6: Abu Dhabi International Medical Services Revenue by Private and Public Sales in terms of Percentage, CY2015
Figure 4-7: Abu Dhabi International Medical Services Revenue by Application of Device (Diagnostic Imaging, Surgical Instruments, Consumables, and Hospital Furniture) in terms of Percentage, CY2015
Figure 4-8: Abu Dhabi International Medical Services Revenue by Emirates (Abu Dhabi, Dubai, and Others) in terms of Percentage, CY2015
Figure 4-9: Atlas Medical Revenue by Private and Public Sales in terms of Percentage, CY2015
Figure 4-10: Atlas Medical Revenue by Application of Device (Diagnostic Imaging, Surgical Instruments, Consumables, and Hospital Furniture) in terms of Percentage, CY2015
Figure 4-11: Atlas Medical Revenue by Emirates (Abu Dhabi, Dubai, and Others) in terms of Percentage, CY2015
Figure 4-12: UAE Medical Devices Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 4-13: UAE Medical Devices Market Outlook and Future Projections by Type of Application (Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants, and Others) on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 5-1: UAE Pharmaceuticals Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 5-2: UAE Pharmaceuticals Market Segmentation by Patented and Generic Drugs on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 5-3: UAE Pharmaceuticals Market Segmentation by Prescribed and OTC Drugs on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 5-4: UAE Pharmaceuticals Market Segmentation by Imports and Domestic Demand on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 5-5: UAE Pharmaceuticals Market Segmentation by Therapeutic Area (Cardiovascular, Diabetes, Respiratory, Anti-infective, Supplementary and Nutritional Products, and Others) on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 5-6: Procedure for Patent Approval of Pharmaceuticals in UAE
Figure 5-7: Julphar Operating History
Figure 5-8: Julphar UAE Revenue in terms of USD Million, CY2013 - CY2015
Figure 5-9: Julphar Revenue Contribution by Top Five Products in terms of USD Million, CY2015
Figure 5-10: Julphar Revenue Contribution by Private and Government Sector in terms of Percentage, CY2015
Figure 5-11: Julphar Revenue Contribution by Therapeutic Area (Systemetic Anti-infective, Alimentary T & Metabolism, Dermatological, Central Nervous System, Blood + B. Forming Organs, Respiratory Systems, Cardiovascular Systems, Diabetics, and Others) in terms of Percentage, CY2015
Figure 5-12: Globalpharma UAE Revenue (Estimated) in terms of USD Million, CY2013 - CY2015
Figure 5-13: UAE Pharmaceuticals Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 5-14: UAE Pharmaceuticals Market Outlook and Future Projections by Generic and Patented Drugs on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 6-1: UAE Pharmacy Retail Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 6-2: UAE Pharmacy Retail Market on the basis of Number of Pharmacies, CY2010 - CY2015
Figure 6-3: UAE Pharmacy Retail Market by Emirates on the Basis of Number of Pharmacies in terms of Percentage, CY2015
Figure 7-1: UAE Hospitals Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 7-2: UAE Hospitals Market on the basis of Number of Hospitals, CY2010 - CY2015
Figure 7-3: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Hospitals in terms of Percentage, CY2010 - CY2015
Figure 7-4: UAE Hospitals Market on the basis of Number of Beds, CY2010 - CY2015
Figure 7-5: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Beds in terms of Percentage, CY2010 - CY2015
Figure 7-6: UAE Hospitals Market on the basis of Number of Inpatients, CY2010 - CY2015
Figure 7-7: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Inpatients, CY2010 - CY2015
Figure 7-8: UAE Hospitals Market on the basis of Number of Outpatients, CY2010 - CY2015
Figure 7-9: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Outpatients, CY2010 - CY2015
Figure 7-10: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 7-11: UAE Hospitals Market Segmentation by Inpatient and Outpatient Revenue, and Hospital Based Pharmacy on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 7-12: UAE Hospitals Market Segmentation by Single-specialty and Multi-specialty Hospitals Revenue on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 7-13: Process for New Healthcare Facility License in Dubai
Figure 7-14: Distribution of JCI Accredited Healthcare Center in the UAE by Emirates on the basis of Number of Organizations in terms of Percentage, CY2014
Figure 7-15: Distribution of JCI Accredited Healthcare Center in the UAE by Type of Healthcare Provider on the basis of Number of Organizations in terms of Percentage, CY2014
Figure 7-16: Dubai Out-bound Medical Travelers in terms of Number of Medical Travelers, 2003 - 2015
Figure 7-17: UAE Hospitals Business Model
Figure 7-18: NMC Healthcare Organizational Structure
Figure 7-19: Financial Performance of NMC Healthcare on the basis of Total Revenue and Growth Rate in terms of USD Million, CY2013 - CY2015
Figure 7-20: Financial Performance of NMC Healthcare on the basis of EBITDA in terms of USD Million, CY2013 - CY2015
Figure 7-21: Financial Performance of NMC Healthcare - Healthcare Branch on the basis of Total Revenue and Growth Rate in terms of USD Million, CY2013 - CY2015
Figure 7-22: Financial Performance of NMC Healthcare - Healthcare Branch by Type of Service on the basis of Revenue Contribution in terms of Percentage, CY2013 - CY2015
Figure 7-23: Financial Performance of NMC Healthcare - Healthcare Branch on the basis of EBITDA in terms of USD Million, CY2013 - CY2015
Figure 7-24: Financial Performance of Zulekha Healthcare Group on the basis of Estimated Contribution by Hospitals in terms of USD Million, CY2013 - CY2015
Figure 7-25: Financial Performance of Mediclinic Middle East (Excluding Al Noor Hospitals) on the basis of Total Revenue in terms of USD Million, FY2013 - FY2015
Figure 7-26: Financial Performance of Mediclinic Middle East (Excluding Al Noor Hospitals) on the basis of EBITDA in terms of USD Million, FY2013 - FY2015
Figure 7-27: Financial Performance of Al Noor Hospitals (Before Acquisition) on the basis of Total Revenue in terms of USD Million, FY2013 - FY2015
Figure 7-28: VPS Healthcare Organization Structure
Figure 7-29: UAE Hospitals Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 7-30: UAE Hospitals Market Outlook and Future Projections by Private and Public Hospitals on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 8-1: UAE Independent Diagnostic Laboratories Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 8-2: UAE Independent Diagnostic Laboratories Market on the basis of Number of Laboratories, CY2010 - CY2015
Figure 8-3: UAE Independent Diagnostic Laboratory Market by Organized and Unorganized Players the basis of Number of Laboratories terms of Percentage, CY2015
Figure 8-4: UAE Independent Diagnostic Laboratories Market Segmentation by Pathology and Radiology Tests on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 8-5: UAE Independent Diagnostic Laboratory’s Pathologic Tests Market Segmentation by Type of Pathology Tests on the basis of Revenue in terms of Percentage, CY2015
Figure 8-6: UAE Independent Diagnostic Laboratories Market Segmentation by Organized and Unorganized Players on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 8-7: Revenue Stream of Independent Diagnostic Laboratories in UAE
Figure 8-8: UAE Independent Diagnostic Laboratories Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 8-9: UAE Independent Diagnostic Laboratories Market Outlook and Future Projections by Organized and Unorganized Players on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 9-1: UAE Clinics/Polyclinics Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 9-2: UAE Clinics/Polyclinics Market on the basis of Number of Clinics/Polyclinics, CY2010 - CY2015
Figure 9-3: UAE Clinics/Polyclinics by Clinics and Polyclinics on the Basis of Number of Clinics/Polyclinics in terms of Percentage, 2015
Figure 9-4: UAE Clinics/Polyclinics by Emirates on the Basis of Number of Clinics/Polyclinics in terms of Percentage, 2015
Figure 9-5: UAE Clinics/Polyclinics Market Segmentation by Clinics and Polyclinics on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 9-6: UAE Clinics/Polyclinics Market Segmentation by Public Clinics/Polyclinics and Private Clinics/Polyclinics on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 9-7: UAE Clinics/Polyclinics Market Segmentation by Outpatients and Diagnostic Services on the Basis of Revenue in terms of Percentage, CY2010 - CY2015
Figure 9-8: UAE Clinics/Polyclinics Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 9-9: UAE Clinics/Polyclinics Market Outlook and Future Projections by Public and Private Clinics/Polyclinics on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 10-1: UAE Telemedicine Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 10-2: Abu Dhabi Telemedicine Center Tele-consultation Process
Figure 10-3: UAE Teleradiology Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 10-4: UAE Telemedicine Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 11-1: UAE Home Healthcare Market on the basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Figure 11-2: UAE Home Healthcare Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 13-1: UAE Healthcare Market Outlook and Future Projections on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Figure 13-2: UAE Healthcare Market Outlook and Future Projections by Segmentation (Medical Devices, Pharmaceuticals, Hospitals, Independent Diagnostic Laboratories, Clinics/Polyclinics, Home Healthcare, and Telemedicine) on the Basis of Revenue in terms of Percentage, CY2016 - CY2020
Figure 14-1: UAE Per Capita Healthcare Spending in terms of USD, CY2010 - CY2015
Figure 14-2: UAE Healthcare Expenditure in terms of USD Billion, CY2010 - CY2015
Figure 14-3: UAE Aging Population on the Basis of People Above 64 Years of Age in Terms of Number of People, CY2010 - CY2015
Figure 14-4: Diabetic Population in UAE in terms of Number of People, CY2010 - CY2015
Figure 14-5: Obese Population in UAE in terms of Number of People, CY2010 - CY2015
Figure 14-6: Medical Tourists in UAE in terms of Number of People, CY2010 - CY2015

Table 2-1: Correlation Matrix for UAE Medical Devices Market
Table 2-2: Regression Coefficients Output
Table 3-1: UAE Healthcare Statistics on the basis of Healthcare Parameters
Table 3-2: UAE Healthcare Statistics on the basis of Incidence Rate of Major Healthcare Problems
Table 3-3: Healthcare Regulatory Sectors in UAE
Table 3-4: Health Insurance in UAE
Table 3-5: UAE Healthcare Market and Rationale for Revenue, CY2010 - CY2015
Table 4-1: UAE Medical Devices Market and Rationale for Revenue, CY2010 - CY2015
Table 4-2: UAE Medical Devices Market by Type of Application and Rationale for Revenue, CY2010 - CY2015
Table 4-3: UAE Medical Devices Market Segmentation by Type of Application (Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants, and Others) on the basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 4-4: UAE Medical Devices Market by Institutional and Household Demand and Rationale for Revenue, CY2010 - CY2015
Table 4-5: UAE Institutional and Household Medical Devices Market and Major Products, Margin of Importers, Distribution Channel, and Product Cycle
Table 4-6: UAE Medical Devices Market Segmentation by Institutional and Household Demand on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 4-7: UAE Medical Devices Market by Domestic Demand and Imports and Rationale for Revenue, CY2010 - CY2015
Table 4-8: UAE Medical Devices Market Segmentation by Imports and Domestic Demand on the Basis of Revenue Contribution in terms of USD Million, CY2010 - CY2015
Table 4-9: UAE Medical Devices Market by Emirates and Rationale for Revenue, CY2010 - CY2015
Table 4-10: UAE Medical Devices Market Segmentation by Emirates (Abu Dhabi, Dubai, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain), on the Basis of Revenue, CY2015
Table 4-11: Average Import Duty Structure of Medical Devices in UAE in terms of Percentage, CY2015
Table 4-12: UAE Imported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of Percentage, CY2012 -CY2014
Table 4-13: UAE Imported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of USD Million, CY2012 -CY2014
Table 4-14: UAE Medical Devices Imports Market by Major Countries and Rationale for Import Value
Table 4-15: UAE Imported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution, CY2012 -CY2014
Table 4-16: UAE Exported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of Percentage, CY2012-CY2014
Table 4-17: UAE Exported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of USD Million, CY2012 -CY2014
Table 4-18: UAE Exported Medical Devices Market Segmentation by Types of Products on the Basis of Revenue Contribution, CY2012 - CY2014
Table 4-19: Government Regulations for Medical Devices in UAE for Domestic Manufacturing and Import/ Export
Table 4-20: Steps to Register an Importation Company in UAE for Import Purposes
Table 4-21: Key Partnerships of Medical Devices Companies in the UAE Market and Rationale
Table 4-22: Key Products in the UAE Smart Watch Market and their Price in terms of USD, 2016
Table 4-23: Key Innovative Products in the UAE Medical Devices Market and their Price in terms of USD, 2016
Table 4-24: Competitive Landscape of Gulf Drug LLC including Company Overview, USP, Key Suppliers, Product Segments, Business Strategies, and Number of Employees
Table 4-25: Competitive Landscape of Abu Dhabi International Medical Services including Company Overview, USP, Key Suppliers, Product Segments, Key Clients, Business Strategies, and Number of Employees
Table 4-26: Competitive Landscape of MPC Healthcare including Company Overview, USP, Key Suppliers, Product Segments, Key Clients, and Business Strategies
Table 4-27: Competitive Landscape of Pharmatrade LLC including Company Overview, USP, Key Suppliers, Product Segments, Key Clients, and Business Strategies
Table 4-28: Competitive Landscape of Atlas Medical including Company Overview, USP, Key Suppliers, Product Segments, Key Clients, and Business Strategies
Table 4-29: UAE Medical Devices Market by Importers and Rationale for Revenue, CY2010 - CY2015
Table 4-30: Market Share of Importers (Gulf Drug LLC, Abu Dhabi International Medical Services, MPC, Pharmatrade, Atlas Medical, and Others) in UAE Medical Devices Market by Revenue Contribution, CY2015
Table 4-31: UAE Medical Devices Market by Manufacturers and Rationale for Revenue, CY2010 - CY2015
Table 4-32: Market Share of Manufacturers (GE Healthcare, Philips Medical Systems, Siemens Healthineers) in UAE Medical Devices Market by Revenue Contribution, CY2015
Table 4-33: Comparative Analysis of GE Healthcare, Philips Medical Systems, and Siemens Healthineers on the basis of Supplier, and Products Offered
Table 4-34: Comparative Analysis of GE Healthcare, Philips Medical Systems, and Siemens Healthineers on the basis of Strengths and Weakness
Table 4-35: Decision Making Process to Shortlist Medical Device with Parameters and Weightage in Percentage (%)
Table 4-36: Sample Composition for Decision Making Process for Purchasing Medical Devices
Table 4-37: Future Drivers for UAE Medical Devices Market
Table 4-38: UAE Medical Devices Market Outlook and Future Projections by Type of Application (Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants, and Others) on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 5-1: UAE Pharmaceuticals Market and Rationale for Revenue, CY2010 - CY2015
Table 5-2: UAE Pharmaceuticals Market by Generic and Patented Drugs and Rationale for Revenue, CY2010 - CY2015
Table 5-3: UAE Pharmaceuticals Market Segmentation by Patented and Generic Drugs on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 5-4: UAE Pharmaceuticals Market by OTC and Prescribed Drugs and Rationale for Revenue, CY2010 - CY2015
Table 5-5: UAE Pharmaceuticals Market Segmentation by Prescribed and OTC Drugs on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 5-6: UAE Pharmaceuticals Market by Domestic Demand and Imports and Rationale for Revenue, CY2010 - CY2015
Table 5-7: UAE Pharmaceuticals Market Segmentation by Imports and Domestic Demand on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 5-8: UAE Pharmaceuticals Market by Therapeutic Area and Rationale for Revenue, CY2010 - CY2015
Table 5-9: UAE Pharmaceuticals Market Segmentation by Therapeutic Area (Cardiovascular, Diabetes, Respiratory, Anti-infective, Supplementary and Nutritional Products, and Others) on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 5-10: UAE Pharmaceuticals Market by Emirates and Rationale for Revenue, CY2010 - CY2015
Table 5-11: UAE Pharmaceuticals Market Segmentation by Emirates (Abu Dhabi, Dubai, Sharjah, and Others), on the Basis of Revenue CY2010 - CY2015
Table 5-12: UAE Imported Pharmaceuticals Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of Percentage, CY2012-CY2014
Table 5-13: UAE Imported Pharmaceuticals Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of USD Million, CY2010-CY2014
Table 5-14: UAE Pharmaceuticals Imports Market by Major Countries and Rationale for Import Value
Table 5-15: UAE Imported Pharmaceuticals Segmentation by Types of Products on the Basis of Revenue Contribution, CY2010 - CY2014
Table 5-16: UAE Exported Pharmaceuticals Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of Percentage, CY2010 - CY2014
Table 5-17: UAE Exported Pharmaceuticals Market Segmentation by Types of Products on the Basis of Revenue Contribution in terms of USD Million, CY2010 - CY2014
Table 5-18: UAE Exported Pharmaceuticals Market Segmentation by Types of Products on the Basis of Revenue Contribution, CY2012 - CY2014
Table 5-19: Government Regulations for Pharmaceuticals in UAE
Table 5-20: UAE Patent Approval Procedure Specifications
Table 5-21: UAE Patent Charges and Official Fees in terms of USD
Table 5-22: UAE Patent Annuities from the Filing Date of First Filling in terms of USD
Table 5-23: DuBiotech Overview
Table 5-24: UAE Slashing Drug Prices Statistics by Initiatives in terms of Number of Drugs and Percentage Reduction
Table 5-25: Competitive Landscape of Julphar including Company Overview, USP, Product Segments, Key Brands, Number of Registered Products, Corporate Social Responsibility, Certifications and Accreditations, Manufacturing Plants, Business Strategies, and Number of Employees
Table 5-26: Julphar Manufacturing Plants, Products and Production Capacity in terms of Million Units
Table 5-27: Clinical Trials by Julphar, Title, Phase, Initiation Date and Rationale
Table 5-28: Competitive Landscape of Neopharma including Company Overview, USP, Product Segments, Number of Registered Products, Certifications and Accreditations, Manufacturing Plants, Business Strategies, and Number of Employees
Table 5-29: Neopharma Manufacturing Plants, Products and Production Capacity in terms of Million Units
Table 5-30: Competitive Landscape of Globalpharma including Company Overview, USP, Product Segments, Key Brands, Number of Registered Products, Certifications and Accreditations, Manufacturing Plants, Business Strategies, and Number of Employees
Table 5-31: Competitive Landscape of Medpharma including Company Overview, USP, Product Segments, Key Brands, Number of Registered Products, Certifications and Accreditations, Manufacturing Plants, Business Strategies, and Number of Employees
Table 5-32: Medpharma Manufacturing Sections, Products and Production Capacity in terms of Million Units
Table 5-33: UAE Pharmaceuticals Market by Domestic Manufacturers and Rationale for Revenue, CY2010 - CY2015
Table 5-34: UAE Pharmaceuticals Market by Domestic Manufacturers (Julphar, Globalpharma, Neopharma, Medpharma and Others) on the Basis of Revenue Contribution, CY2015
Table 5-35: UAE Pharmaceuticals Market by Importers and Rationale for Revenue, CY2010 - CY2015
Table 5-36: Market Share of Major Importers (City Pharmacy, Modern Pharmaceuticals, Al Baker, Pharmatrade LLC and Others) in UAE Pharmaceuticals Market by Revenue, CY2010 - CY2015
Table 5-37: UAE Pharmaceuticals Market by International Manufacturers and Rationale for Revenue, CY2010 - CY2015
Table 5-38: UAE Pharmaceuticals Market on the Basis of Revenue Contribution by International Manufacturers (Pfizer, GlaxoSmithKline, Sanofi, Astrazeneca and Others) CY2010 - CY2015
Table 5-39: Key Pharmaceutical Products Launched in UAE, Company, Year and Applications, CY2010 - CY2016
Table 5-40: Future Drivers for UAE Pharmaceuticals Market
Table 5-41: UAE Pharmaceuticals Market Outlook and Future Projections by Generic and Patented Drugs on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 6-1: UAE Pharmacy Retail Market Key Point Indicators (KPIs), CY2015
Table 6-2: Competitive Landscape of Life Pharmacy including Company Overview, USP, Product Segments, Number of Stores, Number of Locations, Number of Customer Walk-ins per Year, Business Strategies, and Number of Employees
Table 6-3: UAE Life Pharmacy on the basis of Store Locations in terms of Percentage and Number of Pharmacies, 2015
Table 6-4: Competitive Landscape of Bin Sina Pharmacy including Company Overview, USP, Product Segments, Number of Stores, Number of Locations, Number of Customer Walk-ins per Year, Business Strategies, and Number of Employees
Table 6-5: UAE Life Pharmacy on the Basis of Store Locations in terms of Percentage and Number of Pharmacies, 2015
Table 6-6: Competitive Landscape of Aster Pharmacy including Company Overview, USP, Product Segments, Number of Stores, Number of Locations, Business Strategies, and Number of Employees
Table 6-7: UAE Aster Pharmacy on the Basis of Store Locations in terms of Percentage and Number of Pharmacies, 2015
Table 6-8: Competitive Landscape of Super Care Pharmacy including Company Overview, USP, Product Segments, Number of Stores, Number of Locations, Business Strategies, and Number of Employees
Table 6-9: UAE Super Care Pharmacy on the Basis of Store Locations in terms of Percentage and Number of Pharmacies, 2015
Table 6-10: Regulated Margins of Retail Pharmacies in UAE, 2013
Table 7-1: UAE Hospitals Market and Rationale for Revenue, CY2010 - CY2015
Table 7-2: UAE Hospitals Market and Rationale for Number of Hospitals, CY2010 - CY2015
Table 7-3: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Hospitals, CY2010 - CY2015
Table 7-4: UAE Hospitals Market and Rationale for Number of Beds, CY2010 - CY2015
Table 7-5: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Beds, CY2010 - CY2015
Table 7-6: UAE Hospitals Market and Rationale for Number of Inpatients, CY2010 - CY2015
Table 7-7: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Inpatients, CY2010 - CY2015
Table 7-8: UAE Hospitals Market and Rationale for Number of Outpatients, CY2010 - CY2015
Table 7-9: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Number of Beds, CY2010 - CY2015
Table 7-10: UAE Hospitals Market by Public and Private Hospitals and Rationale for Revenue, CY2010 - CY2015
Table 7-11: UAE Hospitals Market Segmentation by Public and Private Hospitals on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 7-12: UAE Hospitals Market by Inpatient Revenue, Outpatient Revenue and Hospital-based Pharmacy Rationale for Revenue, CY2010 - CY2015
Table 7-13: UAE Hospitals Market Segmentation by Inpatient Revenue, Outpatient Revenue, and Hospital Based Pharmacy on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 7-14: UAE Hospitals Market by Single and Multi-specialty Hospitals and Rationale for Revenue, CY2010 - CY2015
Table 7-15: UAE Hospitals Market Segmentation by Single-specialty and Multi-specialty Hospitals on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 7-16: UAE Hospitals Market by Public and Private Hospitals and Rationale for Revenue, CY2015
Table 7-17: UAE Hospitals Market Segmentation by Emirates (Abu Dhabi, Dubai, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain), on the Basis of Revenue, CY2015
Table 7-18: Government Regulations for Hospitals in UAE
Table 7-19: Dubai License Fee and Timeframe for Hospitals
Table 7-20: Key Partnerships in UAE Hospital Market
Table 7-21: Key Acquisitions in UAE Hospital Market
Table 7-22: Required Parameters and Associated Cost for the Establishment of Hospital in UAE in terms of USD Million
Table 7-23: Annual Expenses in UAE Hospitals in terms of USD Million, CY2015
Table 7-24: Annual Salaries of Hospital Professionals on the basis of Salaries per Profession in terms of USD Million in UAE
Table 7-25: Predicted Annual Expenses in UAE Hospitals in terms of USD Million, CY2016 - CY2017
Table 7-26: Annual Revenue of UAE Hospitals in terms of USD Million, CY2015
Table 7-27: Predicted Annual Revenue of UAE Hospitals in terms of USD Million, CY2016 - CY2017
Table 7-28: Inpatient Revenue of Hospitals in UAE on the Basis of Major Hospitals with 200 or Less Than 200 Beds in terms of USD Million, CY2015
Table 7-29: Inpatient Revenue of Hospitals in UAE on the Basis of Major Hospitals with 400 or Less Than 400 Beds in terms of USD Million, CY2015
Table 7-30: Inpatient Revenue of Hospitals in UAE on the Basis of Major Hospitals with More Than 400 Beds in terms of USD Million, CY2015
Table 7-31: Key Hospital Projects Under Pipeline in the UAE
Table 7-32: Competitive Landscape of NMC Healthcare including Group Overview, Number of Beds, Occupancy Rates, Number of Patients Visited, Average Revenue per Patients, Number of Doctors, Business Strategies, and Number of Employees
Table 7-33: Competitive Landscape of Zulekha Healthcare Group including Group Overview, Number of Beds, Occupancy Rates, Key Services, Number of Departments, Number of Inpatients, Number of Outpatients, ICU Beds, Emergency Rooms, Operating Theater Rooms, Average Length of Stay, Number of Doctors, Business Strategies, and Number of Employees
Table 7-34: Competitive Landscape of American Hospital including Group Overview, Number of Beds, Number of Doctors, Business Strategies, and Number of Employees
Table 7-35: Competitive Landscape of Mediclinic Middle East including Group Overview, Number of Beds, Occupancy Rate, Al Noor Average Inpatient Revenue, Al Noor Average Outpatient Revenue, Number of Doctors, Business Strategies, and Number of Employees
Table 7-36: Competitive Landscape of Al Zahra Hospital including Group Overview, Number of Beds, Occupancy Rate, Al Noor Average Inpatient Revenue, Al Noor Average Outpatient Revenue, Number of Doctors, Business Strategies, and Number of Employees
Table 7-37: Competitive Landscape of Cleveland Clinic Abu Dhabi including Group Overview, Number of Beds, Number of ICU Beds, Post Anesthesia Care Unit, Operating Rooms, Key Departments, Number of Departments, Number of Inpatients, Number of Outpatients, Number of Surgeries, Number of Doctors, Business Strategies, and Number of Employees
Table 7-38: Competitive Landscape of VPS Healthcare including Group Overview, Key Hospital Brands, Number of Beds, Number of Operating Rooms, Number of Patients, Number of Doctors, Business Strategies, and Number of Employees
Table 7-39: Competitive Landscape of Aster DM Healthcare including Group Overview, Key Hospital Brands, Number of Beds, Number of Operating Rooms, Number of Patients, Number of Doctors, Business Strategies, and Number of Employees
Table 7-40: Rationale of Market Share for Major Healthcare Groups in UAE Hospitals Market, CY2015
Table 7-41: Market Share of Major Healthcare Group (NMC Healthcare, Aster Group, Mediclinic Middle East, Cleaveland Clinic, VPS Group) in UAE Hospitals Market by Revenue Contribution, CY2015
Table 7-42: Future Drivers for UAE Hospitals Market
Table 7-43: UAE Hospitals Market Outlook and Future Projections by Public and Private Hospitals on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 8-1: UAE Independent Diagnostic Laboratories Market and Rationale for Revenue, CY2010 - CY2015
Table 8-2: UAE Independent Diagnostic Laboratories Market and Rationale for Number of Independent Diagnostic Laboratories, CY2010 - CY2015
Table 8-3: UAE Independent Diagnostic Laboratories Market by Radiology and Pathology Tests and Rationale for Revenue, CY2010 - CY2015
Table 8-4: UAE Independent Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 8-5: UAE Independent Diagnostic Laboratories Market by Organized and Unorganized Players and Rationale for Revenue, CY2010 - CY2015
Table 8-6: UAE Independent Diagnostic Laboratories Market Segmentation by Organized and Unorganized Players Tests on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 8-7: UAE Independent Diagnostic Laboratories Market by Emirates and Rationale for Revenue, CY2010 - CY2015
Table 8-8: UAE Independent Diagnostic Laboratories Market Segmentation by Emirates (Abu Dhabi, Dubai, Sharjah, and Others), on the Basis of Revenue in USD Million, CY2015
Table 8-9: Government Regulations for Diagnostic Laboratories in UAE
Table 8-10: Key Entrance of Diagnostic Supplies Manufacturing Companies in UAE and Rationale
Table 8-11: Competitive Landscape of Al Borg Medical Laboratories including Group Overview, Locations, Services, Number of Tests Performed, Number of Outpatient Visit, Average Revenue per Outpatient, Estimated Outpatient Revenue, Business Strategies, and Number of Employees
Table 8-12: Competitive Landscape Proficiency Healthcare Diagnostics including Group Overview, Locations, Services, Number of Outpatients Visit, Average Revenue per Outpatient, Estimated Outpatient Revenue, Business Strategies, and Number of Employees
Table 8-13: Competitive Landscape National Reference Laboratory including Group Overview, Locations, Services, Number of Tests Performed, Business Strategies, and Number of Employees
Table 8-14: Competitive Landscape Medsol Diagnostics including Group Overview, Locations, Services, Number of Tests Performed, Business Strategies, and Number of Employees
Table 8-15: Rationale of Market Share for Major Market Players in UAE Independent Diagnostic Laboratories Market, CY2015
Table 8-16: Market Share of Major Players (Proficiency Healthcare Diagnostics, Al Borg, National Reference Laboratories, Medsol Diagnostics, and Others) in UAE Independent Diagnostic Laboratories Market by Revenue Contribution, CY2015
Table 8-17: Future Drivers for UAE Independent Diagnostic Laboratories Market
Table 8-18: UAE Independent Diagnostic Laboratories Market Outlook and Future Projections by Organized and Unorganized Players on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 9-1: UAE Clinics/Polyclinics Market Key Point Indicators (KPIs), CY2015
Table 9-2: UAE Clinics/Polyclinics Market by Clinics and Polyclinics and Rationale for Revenue, CY2010 - CY2015
Table 9-3: UAE Clinics/Polyclinics Market Segmentation by Clinics and Polyclinics on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 9-4: UAE Clinics/Polyclinics Market by Public Clinics/Polyclinics and Private Clinics/Polyclinics and Rationale for Revenue, CY2010 - CY2015
Table 9-5: UAE Clinics/Polyclinics Market Segmentation by Public Clinics/Polyclinics and Private Clinics/Polyclinics on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 9-6: UAE Clinics/Polyclinics Market by Outpatient and Diagnostic Services and Rationale for Revenue, CY2010 - CY2015
Table 9-7: UAE Clinics/Polyclinics Market Segmentation by Outpatients and Diagnostic Services on the Basis of Revenue in terms of USD Million, CY2010 - CY2015
Table 9-8: UAE Clinics/Polyclinics Market by Emirates and Rationale for Revenue, CY2010 - CY2015
Table 9-9: UAE Clinics/Polyclinics Market Segmentation by Emirates (Abu Dhabi, Dubai, Sharjah, and Others), on the Basis of Revenue, CY2015
Table 9-10: Comparative Analysis of Major Multispecialty Clinics/Polyclinics in the UAE and its Locations, Departments, and Rationale
Table 9-11: Comparative Analysis of Major Multispecialty Clinics/Polyclinics in the UAE and its Number of Patients per Day, and Consultation Fee per Patient
Table 9-12: Future Drivers for UAE Clinics/Polyclinics Market
Table 9-13: UAE Clinics/Polyclinics Market Outlook and Future Projections by Public and Private Clinics/Polyclinics on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 10-1: Company Profile of Abu Dhabi Telemedicine Center including Overview, Number of Patients, Business Strategies, Health Insurance, Recent Development and Number of Employees
Table 10-2: Company Profile of Ver2 including Overview, Services, and Business Strategies
Table 10-3: Company Profile of Global Hawk Imaging and Diagnostics including Overview, Services, Locations, USP and Business Strategies
Table 10-4: Government Regulations for Telemedicine in UAE
Table 10-5: Future Drivers for UAE Telemedicine Market
Table 11-1: Company Profile of Americare Home Health Services including Overview, Services, and Business Strategies
Table 11-2: Company Profile of Manzil Healthcare Services including Overview, Services, and Business Strategies
Table 11-3: Company Profile of Emirati Canadian Home Healthcare Services including Overview, Services, and Business Strategies
Table 11-4: Future Drivers for UAE Home Healthcare Market
Table 12-1: SWOT Analysis for UAE Healthcare Market
Table 13-1: Cause and Effect Relationship between Industry Factors and Expected Industry Prospects in the UAE Healthcare Market
Table 13-2: Future Drivers for UAE Healthcare Market
Table 13-3: UAE Healthcare Market Outlook and Future Projections by Segmentation (Medical Devices, Pharmaceuticals, Hospitals, Independent Diagnostic Laboratories, Clinics/Polyclinics, Home Healthcare, and Telemedicine) on the Basis of Revenue in terms of USD Million, CY2016 - CY2020
Table 13-4: Recommendations for Healthcare Market in UAE
Table 14-1: Rationale for Per Capita Healthcare Spending In UAE, CY2010 - CY2020
Table 14-2: Rationale for Rising Government Expenditure on Healthcare in UAE, 2010 - CY2020
Table 14-3: Rationale for Rising Aging Population in UAE, 2010 - CY2020
Table 14-4: Rationale Prevalence of Diabetes and Obesity in UAE, 2010 - CY2020
Table 14-5: Rationale for Medical Tourism in UAE, 2010 - CY2020

★調査レポート[UAEのヘルスケア市場見通し]販売に関する免責事項
★調査レポート[UAEのヘルスケア市場見通し]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆